{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:42:38Z","timestamp":1789094558772,"version":"build-2803163510"},"reference-count":34,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,26]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Signal transduction and activator of transcription 3 hyperimmunoglobulin E syndrome (STAT3-HIES) is a multisystem disorder causing recurrent skin and respiratory infection with bronchiectasis, pneumatoceles, and aspergillosis; lymphoma; and extraimmune manifestations including fractures and vasculopathy. Published data on immune and extraimmune hematopoietic stem cell transplant (HSCT) outcomes focus on case reports or small cohorts. We conducted an international multicenter retrospective study of HSCT in STAT3-HIES. Primary end points were overall survival (OS) and event-free survival (EFS; events were death, graft failure, chronic graft-versus-host disease [GVHD]). We identified 41 patients over a 28-year period. HSCT indication was infection (93%) or lymphoma (7%). Median age at HSCT was 14\u2005years (range, 4-45). Most patients had pre-HSCT respiratory disease (93%), including parenchymal lung disease (68%), and prior suspected\/confirmed pulmonary fungal infection (32%). Patients received peripheral blood stem cells (51%) or marrow (49%) from HLA 10\/10\u2013matched unrelated donors (44%), matched family donors (44%), mismatched family donors (10%), or 1\u20059\/10\u2013mismatched unrelated donor (2%). Conditioning regimens were predominantly treosulfan-based (59%; with thiotepa, 34%); other patients received busulfan-based (24%) or melphalan-based (17%) regimens. Median follow-up for surviving patients was 5 years (0.8-28). The 5-year OS was 93%, and 5-year EFS 90%. Cumulative incidence of grade 2 to 4 acute GVHD was 22%. Median whole blood donor chimerism at latest follow-up was 100%. Eighty-seven percent of patients have reduced or no bacterial or fungal respiratory infection. After HSCT, 20% developed new skeletal fractures. This worldwide study expanded data on HSCT for STAT3-HIES to 41 patients; despite significant pre-HSCT pulmonary morbidity, OS was high, and patients have improved skin and respiratory disease though the impact on extraimmune manifestations appears limited.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016158","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T18:00:33Z","timestamp":1750442433000},"page":"4126-4135","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1368-104X","authenticated-orcid":false,"given":"Christo","family":"Tsilifis","sequence":"first","affiliation":[{"name":"1Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children\u2019s Hospital, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom"},{"name":"2Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0979-7274","authenticated-orcid":false,"given":"Johannes","family":"Raedler","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Dr. von Hauner Children\u2019s Hospital, University Hospital, Ludwig Maximilian University Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-9190","authenticated-orcid":false,"given":"Joanna","family":"Renke","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Hematology and Oncology, Medical University of Gda\u0144sk, Gda\u0144sk, Poland"},{"name":"5Outdoor Department of Clinical Immunology for Children, University Clinical Centre, Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-7747","authenticated-orcid":false,"given":"Michael","family":"Medinger","sequence":"additional","affiliation":[{"name":"6Department of Hematology, University Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2354-2588","authenticated-orcid":false,"given":"Alexandra","family":"Laberko","sequence":"additional","affiliation":[{"name":"7Department of Hematopoietic Stem Cell Transplantation, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1sgeir","family":"Haraldsson","sequence":"additional","affiliation":[{"name":"8Children\u2019s Hospital Iceland, Landspitali \u2013 University Hospital, Reykjav\u00edk, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Patel","sequence":"additional","affiliation":[{"name":"9Division of Allergy and Immunology, Department of Pediatrics, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ciznar","sequence":"additional","affiliation":[{"name":"10Pediatric Department, Comenius University Medical Faculty, National Institute of Children's Diseases, Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Wong","sequence":"additional","affiliation":[{"name":"11Allergy and Immunology, Children\u2019s Hospital at Westmead, Westmead, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Keogh","sequence":"additional","affiliation":[{"name":"12Cancer Centre for Children, Children\u2019s Hospital at Westmead, Westmead, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2057-3968","authenticated-orcid":false,"given":"Paul","family":"Gray","sequence":"additional","affiliation":[{"name":"13Allergy and Immunology, Sydney Children\u2019s Hospital, Sydney, NSW, Australia"},{"name":"14School of Medicine, Western Sydney University, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mitchell","sequence":"additional","affiliation":[{"name":"15Kids Cancer Centre, Sydney Children\u2019s Hospital, Randwick, NSW, Australia"},{"name":"16School of Women & Children\u2019s Health, University of New South Wales, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venetia","family":"Bigley","sequence":"additional","affiliation":[{"name":"2Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"},{"name":"17Northern Centre for Bone Marrow Transplantation, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7455-9477","authenticated-orcid":false,"given":"Suzanne","family":"Elcombe","sequence":"additional","affiliation":[{"name":"18Department of Immunology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9644-2003","authenticated-orcid":false,"given":"Fabian","family":"Hauck","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Dr. von Hauner Children\u2019s Hospital, University Hospital, Ludwig Maximilian University Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9143-3263","authenticated-orcid":false,"given":"Michael H.","family":"Albert","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Dr. von Hauner Children\u2019s Hospital, University Hospital, Ludwig Maximilian University Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tholouli","sequence":"additional","affiliation":[{"name":"19Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Herwadkar","sequence":"additional","affiliation":[{"name":"20Department of Clinical Immunology, Salford Care Organisation, Northern Care Alliance NHS Trust, Salford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6292-6795","authenticated-orcid":false,"given":"Shuayb","family":"Elkhalifa","sequence":"additional","affiliation":[{"name":"21Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom"},{"name":"22Allergy and Immunology Division, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0662-1265","authenticated-orcid":false,"given":"Chris","family":"Kosmidis","sequence":"additional","affiliation":[{"name":"23National Aspergillosis Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2351-4656","authenticated-orcid":false,"given":"Giorgio","family":"Callisti","sequence":"additional","affiliation":[{"name":"24Infectious Diseases Department, Manchester University NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-4740","authenticated-orcid":false,"given":"Lauri M.","family":"Burroughs","sequence":"additional","affiliation":[{"name":"25Fred Hutchinson Cancer Research Center, Department of Pediatrics, University of Washington, Seattle Children\u2019s Hospital, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5593-436X","authenticated-orcid":false,"given":"Karin","family":"Chen","sequence":"additional","affiliation":[{"name":"26Division of Immunology, Department of Pediatrics, University of Washington and Seattle Children\u2019s Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7914-0799","authenticated-orcid":false,"given":"Ben","family":"Carpenter","sequence":"additional","affiliation":[{"name":"27University College London Institute of Immunity and Transplantation, University College London, London, United Kingdom"},{"name":"28Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1163-2295","authenticated-orcid":false,"given":"Thomas A.","family":"Fox","sequence":"additional","affiliation":[{"name":"27University College London Institute of Immunity and Transplantation, University College London, London, United Kingdom"},{"name":"28Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-1130","authenticated-orcid":false,"given":"Emma C.","family":"Morris","sequence":"additional","affiliation":[{"name":"27University College London Institute of Immunity and Transplantation, University College London, London, United Kingdom"},{"name":"28Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom"},{"name":"29Department of Immunology, Royal Free London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5771-8214","authenticated-orcid":false,"given":"Ramya","family":"Uppuluri","sequence":"additional","affiliation":[{"name":"30Paediatric Haemato-Oncology, Apollo Hospitals, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revathi","family":"Raj","sequence":"additional","affiliation":[{"name":"30Paediatric Haemato-Oncology, Apollo Hospitals, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1055-6497","authenticated-orcid":false,"given":"Masakatsu","family":"Yanagimachi","sequence":"additional","affiliation":[{"name":"31Department of Pediatrics, Yokohama City University, Yokohama, Japan"},{"name":"32Division of Hematology\/Oncology, Kanagawa Children\u2019s Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2755-9408","authenticated-orcid":false,"given":"Emilie P.","family":"Buddingh","sequence":"additional","affiliation":[{"name":"33Pediatric Stem Cell Transplantation Program, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2053-0191","authenticated-orcid":false,"given":"Christina","family":"Oikonomopoulou","sequence":"additional","affiliation":[{"name":"34Stem Cell Transplant Unit, Aghia Sofia Children\u2019s Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"35Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4868-6852","authenticated-orcid":false,"given":"Dimana","family":"Dimitrova","sequence":"additional","affiliation":[{"name":"36Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Kanakry","sequence":"additional","affiliation":[{"name":"36Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7501-806X","authenticated-orcid":false,"given":"Danielle","family":"Arnold","sequence":"additional","affiliation":[{"name":"35Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0158-8147","authenticated-orcid":false,"given":"Sung-Yun","family":"Pai","sequence":"additional","affiliation":[{"name":"35Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Slatter","sequence":"additional","affiliation":[{"name":"1Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children\u2019s Hospital, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom"},{"name":"2Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-3779","authenticated-orcid":false,"given":"Mark S.","family":"Pearce","sequence":"additional","affiliation":[{"name":"37Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-7385","authenticated-orcid":false,"given":"Austen","family":"Worth","sequence":"additional","affiliation":[{"name":"38Department of Immunology and Gene Therapy, Great Ormond Street Hospital for Children, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[{"name":"39Laboratory of Clinical Immunology and Microbiology, National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[{"name":"1Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children\u2019s Hospital, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom"},{"name":"2Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"16","key":"2025082608215231900_bib1","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"issue":"7157","key":"2025082608215231900_bib2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"issue":"3","key":"2025082608215231900_bib3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","article-title":"Autosomal dominant hyper-IgE syndrome in the USIDNET Registry","volume":"6","author":"Gernez","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2025082608215231900_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3476(03)00449-9","article-title":"Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity","volume":"144","author":"Renner","year":"2004","journal-title":"J Pediatr"},{"issue":"4","key":"2025082608215231900_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"2025082608215231900_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections \u2014 an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"2025082608215231900_bib7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","article-title":"STAT3 hyper-IgE syndrome\u2014an update and unanswered questions","volume":"41","author":"Tsilifis","year":"2021","journal-title":"J Clin Immunol"},{"issue":"2","key":"2025082608215231900_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10875-015-0231-8","article-title":"Autosomal dominant hyper IgE syndrome \u2013 treatment strategies and clinical outcomes","volume":"36","author":"Flinn","year":"2016","journal-title":"J Clin Immunol"},{"issue":"12","key":"2025082608215231900_bib9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.bmt.1702446","article-title":"Bone marrow transplantation does not correct the hyper IgE syndrome","volume":"25","author":"Gennery","year":"2000","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"2025082608215231900_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9343(98)00200-9","article-title":"Effects of allogeneic peripheral stem cell transplantation in a patient with Job syndrome of hyperimmunoglobulinemia E and recurrent infections","volume":"105","author":"Nester","year":"1998","journal-title":"Am J Med"},{"issue":"5","key":"2025082608215231900_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10875-016-0278-1","article-title":"The potential and limits of hematopoietic stem cell transplantation for the treatment of autosomal dominant hyper-IgE syndrome","volume":"36","author":"Yanagimachi","year":"2016","journal-title":"J Clin Immunol"},{"issue":"2","key":"2025082608215231900_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jaci.2010.05.005","article-title":"Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome","volume":"126","author":"Goussetis","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2025082608215231900_bib13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s10875-021-00971-2","article-title":"Hematopoietic stem cell transplantation resolves the immune deficit associated with STAT3-dominant-negative hyper-IgE syndrome","volume":"1","author":"Harrison","year":"2021","journal-title":"J Clin Immunol"},{"issue":"September","key":"2025082608215231900_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fped.2020.00575","article-title":"Hematopoietic stem cell transplantation and vasculopathy associated with STAT3-dominant-negative hyper-IgE syndrome","volume":"8","author":"Ponsford","year":"2020","journal-title":"Front Pediatr"},{"issue":"9","key":"2025082608215231900_bib15","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.21873\/anticanres.15952","article-title":"Treosulfan-based reduced-intensity allogeneic hematopoietic cell transplantation in adults with primary immunodeficiency: a case series","volume":"42","author":"Dalla Via","year":"2022","journal-title":"Anticancer Res"},{"issue":"1","key":"2025082608215231900_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbmt.2019.08.018","article-title":"Prospective study of a novel, radiation-free, reduced-intensity bone marrow transplantation platform for primary immunodeficiency diseases","volume":"26","author":"Dimitrova","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"issue":"February","key":"2025082608215231900_bib17","doi-asserted-by":"crossref","first-page":"626593","DOI":"10.3389\/fimmu.2021.626593","article-title":"Clinical profile of hyper-IgE syndrome in India","volume":"12","author":"Saikia","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"2025082608215231900_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10875-015-0167-z","article-title":"Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome","volume":"35","author":"Patel","year":"2015","journal-title":"J Clin Immunol"},{"key":"2025082608215231900_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-030-02278-5_41","volume-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]","author":"Valc\u00e1rcel","year":"2019","edition":"7th ed"},{"issue":"11","key":"2025082608215231900_bib20","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transpl"},{"issue":"12","key":"2025082608215231900_bib21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"2025082608215231900_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"issue":"10","key":"2025082608215231900_bib23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.2020005590","article-title":"Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults","volume":"136","author":"Chiesa","year":"2020","journal-title":"Blood"},{"issue":"6","key":"2025082608215231900_bib24","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jaci.2018.12.1010","article-title":"Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT\/ESID-IEWP-SCETIDE-PIDTC study","volume":"143","author":"Ferrua","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"2025082608215231900_bib25","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood-2018-09-876284","article-title":"The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases","volume":"133","author":"Thakar","year":"2019","journal-title":"Blood"},{"issue":"22","key":"2025082608215231900_bib26","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1182\/bloodadvances.2024013484","article-title":"Pediatric Adapted Risk index (PARI) to predict 2-year transplant related mortality post-HSCT in children","volume":"8","author":"Elfeky","year":"2024","journal-title":"Blood Adv"},{"issue":"8","key":"2025082608215231900_bib27","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"4","key":"2025082608215231900_bib28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.117.4.1139","article-title":"The metabolism of IgE: studies in normal individuals and in a patient with IgE myeloma1","volume":"117","author":"Waldmann","year":"1976","journal-title":"J Immunol"},{"issue":"Pt B","key":"2025082608215231900_bib29","doi-asserted-by":"crossref","first-page":"111031","DOI":"10.1016\/j.intimp.2023.111031","article-title":"The mechanism underlying the inverse proportion between serum IgE concentration and Stat3 transcriptional activity depends on Stat3 mutation type","volume":"124","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"2025082608215231900_bib30","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1007\/s10875-021-01069-5","article-title":"Lineage-specific chimerism and outcome after hematopoietic stem cell transplantation for DOCK8 deficiency","volume":"41","author":"Raedler","year":"2021","journal-title":"J Clin Immunol"},{"issue":"1","key":"2025082608215231900_bib31","doi-asserted-by":"crossref","first-page":"44.e1","DOI":"10.1016\/j.jtct.2021.08.019","article-title":"Bone health outcomes at 1 year after hematopoietic stem cell transplantation in a heterogeneous pediatric population","volume":"28","author":"Swauger","year":"2022","journal-title":"Transpl Cell Ther"},{"issue":"2","key":"2025082608215231900_bib32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10875-013-9982-2","article-title":"Bone density and fractures in autosomal dominant hyper IgE syndrome","volume":"34","author":"Sowerwine","year":"2014","journal-title":"J Clin Immunol"},{"issue":"9","key":"2025082608215231900_bib33","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"2025082608215231900_bib34","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/genes13101912","article-title":"Allele-specific disruption of a common STAT3 autosomal dominant allele is not sufficient to restore downstream signaling in patient-derived T cells","volume":"13","author":"K\u00f6nig","year":"2022","journal-title":"Genes (Basel)"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/16\/4126\/2406466\/blooda_adv-2025-016158-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/16\/4126\/2406466\/blooda_adv-2025-016158-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T12:22:02Z","timestamp":1756210922000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/16\/4126\/537882\/Allogeneic-hematopoietic-stem-cell-transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":34,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,8,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016158","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8,26]]},"published":{"date-parts":[[2025,8,13]]}}}